000 | 01568 a2200457 4500 | ||
---|---|---|---|
005 | 20250511180801.0 | ||
264 | 0 | _c19931116 | |
008 | 199311s 0 0 eng d | ||
022 | _a0044-0086 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGorelick, F S | |
245 | 0 | 0 |
_aIntracellular proteolysis of pancreatic zymogens. _h[electronic resource] |
260 |
_bThe Yale journal of biology and medicine _c |
||
300 |
_a407-20; discussion 437-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzamidines _xpharmacology |
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 |
_aCarbachol _xpharmacology |
650 | 0 | 4 | _aCarboxypeptidase B |
650 | 0 | 4 |
_aCarboxypeptidases _xmetabolism |
650 | 0 | 4 | _aCarboxypeptidases A |
650 | 0 | 4 |
_aCholecystokinin _xpharmacology |
650 | 0 | 4 |
_aChymotrypsinogen _xmetabolism |
650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Precursors _xmetabolism |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 |
_aLeucine _xanalogs & derivatives |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aPancreas _xcytology |
650 | 0 | 4 |
_aPancreatitis _xetiology |
650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTrypsin Inhibitors _xpharmacology |
700 | 1 | _aModlin, I M | |
700 | 1 | _aLeach, S D | |
700 | 1 | _aCarangelo, R | |
700 | 1 | _aKatz, M | |
773 | 0 |
_tThe Yale journal of biology and medicine _gvol. 65 _gno. 5 _gp. 407-20; discussion 437-40 |
|
999 |
_c1346581 _d1346581 |